Nuclidium

Bioscience & Disease Healthcare Systems Deep Tech

Bioscience & Disease Healthcare Systems +1

Website Zurich

About Nuclidium

Nuclidium is a clinical-stage biotechnology company pioneering the development of next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer. The company aims to address the persistent unmet need in oncology by providing personalized treatment options for cancer patients at every stage of their journey.

Business Information

Target Customers

hospitals oncology clinics healthcare providers

Industry Categories

Bioscience & Disease Healthcare Systems Deep Tech

Business Model

Revenue Model B2B

Pricing Strategy Negotiated contracts with healthcare institutions

Sales Channels direct sales, partnerships with healthcare providers

Funding Timeline

Round	Date	Amount	Investors
Series B	Jul 18, 2025	$99.0M	Unknown
Series B	Jul 10, 2025	$84.0M	Unknown

Founders

No founder information available.

Investors

No investor information available.

Recent Mentions

Raising.fi @raisingfi

Jul 10, 2025

New Raise 🏛️ Company: Nuclidium 🔗 Website: https://t.co/tEVJii3m2X 📊 Amount: €84 Million 🔄 Round: Series B 🧮 Valuation: N/A ⚙️ Industry: Biotechnology, Healthcare

View on Twitter

Deep Chakraborty @deep_smm2021

Jul 18, 2025

Three biotech companies raised $229M COMBINED this week: → Nuclidium: $99M Series B (cancer diagnostics) → Actithera: $75.5M Series A (radioconjugates) → One Biosciences: €15M Series A (AI tumor analysis) Clinical-stage biotech is back, Boss.

View on Twitter

Similar Startups

QNu Labs

85% match

QNu Labs is involved in the quantum technology sector, specializing in post-quantum cryptography and...

Alpheus Medical

85% match

A private, clinical-stage oncology company focused on developing innovative therapies for cancer tre...

Nuvo

84% match

B2B trade network

Clarium

83% match

Clarium is a healthcare technology startup that is transforming the hospital supply chain through it...